DEXAMETHASONE phosphate, 4mg/ml, 1ml, amp.
STD
DINJDEXA4A-
Valid Article
Account code:
60000
HS Code:
300432
Last Updated on:
21/11/2024, 22:15:21
Former
Code(s):
-X DINJZBD0054
17.2 - Antiemetic medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
2.3 - Medicines for other common symptoms in palliative care
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
22.5 - Other medicines administered to the mother
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
3 - Antiallergics and medicines used in anaphylaxis
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
8.2.4 - Hormones and antihormones
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
H02AB02
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
DEXAMETHASONE
Therapeutic Action
Steroid anti-inflammatory (corticosteroid)
Indications
Inflammatory syndrome in severe infections (severe typhoid fever, acute subglottic laryngitis, etc.) when oral route is not possible.
Foetal lung maturation
Treatment of severe cases of Covid-19. Refer to your OC advisor for specific protocols.
Instructions for use
Each 1 ml ampoule contains 4 mg dexamethasone phosphate.
Must be given as IM or IV injection or IV infusion.
Storage
- Below 25ºC - Protect from sunlight
- Do not freeze (the solution precipitates at 0°C).